PCVX logo

PCVX

Vaxcyte Inc.

$30.79
+$0.02(+0.06%)
28
Overall
--
Value
30
Tech
26
Quality
Market Cap
$3.93B
Volume
944.90K
52W Range
$27.66 - $121.06
Target Price
$114.88
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
OPERATING EXPENSES
Operating Expenses
$89.6M$103.7M$232.3M$468.0M$569.5M
Research & Development
$73.6M$78.4M$169.5M$332.3M$476.6M
Research Expense
$73.6M$78.4M$169.5M$332.3M$476.6M
Selling, General & Administrative
$16.0M$25.3M$39.8M$60.7M$92.9M
General & Administrative Expenses
$16.0M$25.3M$39.8M$60.7M$92.9M
Depreciation & Amortization
$1.4M$1.8M$2.6M$3.2M$7.0M
Depreciation & Amortization
$1.4M$1.8M------
Other Operating Expenses
$-287.0K$-461.0K------
OPERATING INCOME
Operating income
$-89.6M$-103.7M$-232.3M$-468.0M$-569.5M
EBITDA
$-87.8M$-96.6M$-214.3M$-392.1M$-448.1M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$7.0K$7.0K$2.0K----
Intinc
$244.0K$344.0K$8.4M$62.9M$110.0M
Net Non-Operating Interest Income/Expense
$237.0K$337.0K$8.4M$62.9M$110.0M
Gain on Sale of Securities
--$2.0K------
Other Income/Expense
$-2.5M$-1.6M$-24.5M$-2.9M$4.4M
Other Special Charges
$2.5M$1.6M--$2.9M$-4.4M
SPECIAL ITEMS
Special Income Charges
$-267.0K--$-213.0K----
Impairment of Capital Assets
$267.0K--------
PRE-TAX INCOME
EBIT
$-89.2M$-100.1M$-223.5M$-402.3M$-463.9M
Pre-Tax Income
$-89.2M$-100.1M$-223.5M$-327.3M$-463.9M
NET INCOME
Net Income
$-89.2M$-100.1M$-223.5M$-402.3M$-463.9M
Net Income (Continuing Operations)
$-89.2M$-100.1M$-223.5M$-402.3M$-463.9M
Net Income (Discontinued Operations)
$-89.2M$-100.1M$-223.5M$-402.3M$-463.9M
Net Income (Common Stockholders)
$-89.2M$-100.1M$-223.5M$-402.3M$-463.9M
TOTALS
Total Expenses
$89.6M$103.7M$232.3M$468.0M$569.5M
SHARE & EPS DATA
Average Shares Outstanding
$29.5M$51.9M$64.9M$97.2M$122.0M
Average Shares Outstanding (Diluted)
$29.5M--$64.9M$97.2M$122.0M
Shares Outstanding
$51.3M$56.3M$80.0M$108.4M$128.8M
Basic EPS
$-3.02$-1.93$-3.44$-4.14$-3.8
Basic EPS (Continuing Operations)
$-3.02$-1.93$-3.44$-4.14$-3.8
Diluted EPS
$-3.02$-1.93$-3.44$-4.14$-3.8
Diluted EPS (Continuing Operations)
----$-3.44$-4.14$-3.8
OTHER METRICS
Gain On Sale Of P P E
----$-44.0K----
Other Gand A
$16.0M$25.3M$39.8M$60.7M$92.9M
Rent And Landing Fees
$700.0K--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2PCVX$30.79+0.1%944.90K
3
4
5
6

Get Vaxcyte Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.